Literature DB >> 28919308

Alternative splicing in cancers: From aberrant regulation to new therapeutics.

Xiaowei Song1, Zhenyu Zeng2, Huanhuan Wei3, Zefeng Wang4.   

Abstract

Alternative splicing is one of the most common mechanisms for gene regulation in humans, and plays a vital role to increase the complexity of functional proteins. In this article, we seek to provide a general review on the relationships between alternative splicing and tumorigenesis. We briefly introduce the basic rules for regulation of alternative splicing, and discuss recent advances on dynamic regulation of alternative splicing in cancers by highlighting the roles of a variety of RNA splicing factors in tumorigenesis. We further discuss several important questions regarding the splicing of long noncoding RNAs and back-splicing of circular RNAs in cancers. Finally, we discuss the current technologies that can be used to manipulate alternative splicing and serve as potential cancer treatment.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alternative splicing; Cancer; Engineered splicing factors; RNA-binding protein

Mesh:

Substances:

Year:  2017        PMID: 28919308     DOI: 10.1016/j.semcdb.2017.09.018

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  41 in total

Review 1.  When one becomes many-Alternative splicing in β-cell function and failure.

Authors:  Maria Inês Alvelos; Jonàs Juan-Mateu; Maikel Luis Colli; Jean-Valéry Turatsinze; Décio L Eizirik
Journal:  Diabetes Obes Metab       Date:  2018-09       Impact factor: 6.577

2.  Long non-coding RNA and messenger RNA-the meeting of two worlds.

Authors:  Constance Vennin; Eric Adriaenssens
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

3.  Prognostic alternative splicing signatures and underlying regulatory network in esophageal carcinoma.

Authors:  Zu-Cheng Xie; Hua-Yu Wu; Fu-Chao Ma; Yi-Wu Dang; Zhi-Gang Peng; Hua-Fu Zhou; Gang Chen
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

Review 4.  Impacts and mechanisms of alternative mRNA splicing in cancer metabolism, immune response, and therapeutics.

Authors:  Qiu Peng; Yujuan Zhou; Linda Oyang; Nayiyuan Wu; Yanyan Tang; Min Su; Xia Luo; Ying Wang; Xiaowu Sheng; Jian Ma; Qianjin Liao
Journal:  Mol Ther       Date:  2021-11-15       Impact factor: 11.454

5.  Circ_0039569 promotes renal cell carcinoma growth and metastasis by regulating miR-34a-5p/CCL22.

Authors:  Chengluo Jin; Linmei Shi; Zhexun Li; Wei Liu; Bai Zhao; Yu Qiu; Yakun Zhao; Kunlun Li; Yifei Li; Qingguo Zhu
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

6.  Genome-wide profiling of prognosis-related alternative splicing signatures in sarcoma.

Authors:  Weifeng Hong; Weicong Zhang; Renguo Guan; Yuying Liang; Shixiong Hu; Yayun Ji; Mouyuan Liu; Hai Lu; Min Yu; Liheng Ma
Journal:  Ann Transl Med       Date:  2019-10

7.  Arsenite Exposure Displaces Zinc from ZRANB2 Leading to Altered Splicing.

Authors:  Mayukh Banerjee; Ana P Ferragut Cardoso; Angeliki Lykoudi; Daniel W Wilkey; Jianmin Pan; Walter H Watson; Nichola C Garbett; Shesh N Rai; Michael L Merchant; J Christopher States
Journal:  Chem Res Toxicol       Date:  2020-04-27       Impact factor: 3.739

8.  A prometastatic splicing program regulated by SNRPA1 interactions with structured RNA elements.

Authors:  Lisa Fish; Matvei Khoroshkin; Albertas Navickas; Kristle Garcia; Bruce Culbertson; Benjamin Hänisch; Steven Zhang; Hoang C B Nguyen; Larisa M Soto; Maria Dermit; Faraz K Mardakheh; Henrik Molina; Claudio Alarcón; Hamed S Najafabadi; Hani Goodarzi
Journal:  Science       Date:  2021-05-14       Impact factor: 47.728

9.  Prognostic alternative splicing signature in cervical squamous cell carcinoma.

Authors:  Hua-Yu Wu; Qi-Qi Li; Liang Liang; Lan-Lan Qiu; Hong-Wei Wei; Bing-Ying Huang; Chen Gang-; Rong-Quan He; Zhi-Guang Huang; Wei Hou; Qi-Ping Hu; Shang-Ling Pan
Journal:  IET Syst Biol       Date:  2020-12       Impact factor: 1.615

10.  KRT18 Modulates Alternative Splicing of Genes Involved in Proliferation and Apoptosis Processes in Both Gastric Cancer Cells and Clinical Samples.

Authors:  Biao Chen; Ximing Xu; Dan-Dan Lin; Xin Chen; Yang-Tao Xu; Xin Liu; Wei-Guo Dong
Journal:  Front Genet       Date:  2021-07-05       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.